Dartmouth MA Ketamine & Vitamin Therapy For PTSD, Anxiety & Depression | Update
Nov 15, 2022
Thrive IV (508-848-8089), one of the few clinics offering ketamine infusions, has launched new options for patients suffering from illnesses that are often resistant to traditional treatments, such as PTSD and depression.
Dartmouth,United States - November 15, 2022 /PressCable/ —
Though medicine is constantly advancing, and it often seems as if there is a new cure for something announced every week, for patients suffering from treatment-resistant conditions, it can still seem like nothing is ever going to get better. Thrive IV provides infusions of ketamine at its recently opened clinic in Dartmouth, MA, which have been proven to offer fast relief for a wide range of otherwise treatment-resistant illnesses.
More information about Thrive IV, ketamine infusions, and treatment-resistant conditions can be found at http://www.thriveiv.net
While ketamine is not an option most patients can access through their standard healthcare, it has been made accessible at a very small number of clinics, after overwhelming positive results from decades of medical research. The new Thrive IV clinic offers highly customized treatment options, Monday to Saturday, by appointment only.
The clinic is run by Dr. Michael Pellegrino, who has decades of medical experience both treating patients and studying the effects of ketamine specifically. While the standard treatment is similar for most conditions, the exact dosages, additional nutrients, and schedules are each carefully planned by Dr. Pellegrino to suit the individual patient’s needs.
Thrive IV is currently offering IV ketamine treatments for 5 main categories of difficult-to-treat conditions: Post-Traumatic Stress Disorder (PTSD), Treatment-Resistant Depression (TRD), anxiety disorders, Obsessive-Compulsive Disorder (OCD), and chronic nerve pain. Patients who do not fall into one of these categories, but who believe they may benefit from IV ketamine infusions, can contact the clinic for more information.
While ketamine is rarely used as the first option for treatment, though it is widely considered to be safe with only minor side effects, it has shown consistently positive results as a method for treating conditions that do not respond to traditional drugs or therapy. Though standard options to help patients with Treatment-Resistant Depression, including postpartum depression and bipolar disorder, can fail in 60% of cases or more, ketamine therapy has a success rate of 70-80%.
A spokesperson for the clinic said, “Fast relief for those struggling with depression, PTSD, anxiety, and chronic pain. There is help for you. Ketamine may be the missing puzzle piece you’ve been searching for to help make everything clear with a path to healing your brain and feeling your best.”
More information about treatment options, ketamine infusions, and the Thrive IV clinic can be found at http://www.thriveiv.net
Contact Info:
Name: Dr. Michael Pellegrino
Email: Send Email
Organization: Thrive IV
Address: 49 State Rd Nauset Building #102, Dartmouth, MA 02747, United States
Phone: +1-508-848-8089
Website: http://www.ThriveIV.net
Source: PressCable
Release ID: 89084918
If you detect any issues, problems, or errors in this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 8 hours.
More News
Airlines criticise air traffic control as second glitch causes more disruption
Prime Minister Andy Burnham said further issues "cause even greater concern" about the UK's air traffic control and the head of the organisation that runs it.
Wall Street Is Growing Skeptical of the Data Center Boom
Several companies tied to the data center industry have delayed their initial public offerings amid the increasing public backlash to these energy guzzling facilities.
CNN, MS NOW and Politico to Sue Trump Administration Over White House Access
In a joint statement, CNN, MS NOW and Politico argued that President Trump’s decision to bar them from the White House grounds violates their First Amendment rights.
Anthropic Pursues IPO Despite Its A.I. Safety Warnings
The company is expected to reach $100 billion in annualized revenue this year, even as chief executive Dario Amodei calls for slowing down development of some advanced A.I. models.
What to Do If You’re Laid Off and Too Young for Medicare
At best, older workers will struggle to find health insurance that bridges the years before they qualify for Medicare at age 65.
Repeated air traffic control failures leave us in worrying territory
The question is whether all of these incidents were isolated and unavoidable, or whether they point to something more systemic.
Mistakes? We’ve Made a Few
For most of its life, The New York Times has tried to correct its errors. These efforts have not always been perfect.
The A.I. Party House Where Networking Has a Dark Side
Group tech houses have proliferated across the San Francisco Bay Area in the artificial intelligence boom. One of the most prominent has also racked up an extensive police record.
China Promised to Buy More U.S. Farm Goods. It Hasn’t Happened.
Soybeans are the notable exception, revealing Beijing’s selective approach to fulfilling trade commitments ahead of the summit between President Trump and Xi Jinping.
Young Consultants Are Jumping Ship for A.I. Start-Ups
Beckoned by the glamour of the start-up space, the industry’s college recruits are joining A.I. companies able to outmatch their consulting salaries.
Bessent and China Hail Progress on A.I. Talks. Now Comes the Hard Part.
Artificial intelligence and more are expected to be big issues at this week’s summit between President Trump and Xi Jinping, China’s top leader.
Families missing out on NHS money for healthy food
Figures show as little as 64% of eligible families are claiming NHS money for milk, fruit and veg
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.